Skip to main content
. 2020 Oct 15;25(20):4739. doi: 10.3390/molecules25204739

Table 5.

Bioactivity of Tunisian okra pods (Abelmochus esculentus L. Moench).

Abelmoschus esculentus L. Moench
Antioxidant activity; EC50 = mg/mL A
DPPH scavenging activity 1.03 ± 0.02
FRAP scavenging activity 0.89 ± 0.03
β-carotene bleaching inhibition 0.47 ± 0.02
Cytotoxic activity; IC50 = mg/mL B
NCl-H460 49.62 ± 0.02
MCF-7 56.40 ± 0.30
HeLa 67.30 ± 0.50
HepG-2 168.00 ± 7.00
Anti-hyperglycaemic activity; IC50 = mg/mL C
α-amylase inhibition 0.125 ± 0.02
α-glucosidase inhibition 0.110 ± 0.01
Analgesic Activity
Groups Concentration (mg/kg) Number of Writhes Inhibition of Writhing (%)
Control ----- 81.20 ± 0.40 ------
Tunisian okra pods 10 59.70 ± 0.60 ** 26.48
50 47.00 ± 0.40 ** 42.09
100 34.00 ± 0.30 *** 58.11
Reference drug (ASL) 200 30.00 ± 1.00 *** 63.65

Values are expressed as mean ± S.E.M. (n = 6); ASL: Acetylsalicylate of lysine. A Trolox EC50 values: 0.030 ± 0.001 mg/mL (DDPH), 0.072 ± 0.002 mg/mL (FRAP), and 0.010 ± 0.001 mg/mL (β-carotene bleaching inhibition); B Ellipticine GI50 value: 0.91 ± 0.04 μg/mL (MCF-7), 1.03 ± 0.09 μg/mL (NCI-H460), 1.91 ± 0.06 μg/mL (HeLa), 1.1 ± 0.2 μg/mL (HepG2). C Acarbose IC50 values: 0.093 ± 0.001 mg/mL (α-amylase inhibition) and 0.28 ± 0.01 mg/mL (α-glucosidase inhibition). ** p ≤ 0.01 significant from control; *** p ≤ 0.001 significant from control.